• Home
  • Our Team
  • About Us
  • Contact Us
Friday, September 19, 2025
Jammu Kashmir News Service | JKNS
  • Home
  • Top Stories
  • Kashmir
  • Jammu
  • National
  • Business
  • Sports
  • Oped
  • World
No Result
View All Result
  • Home
  • Top Stories
  • Kashmir
  • Jammu
  • National
  • Business
  • Sports
  • Oped
  • World
No Result
View All Result
Jammu Kashmir News Service | JKNS
No Result
View All Result
Home Top Stories

29 dead in Norway after getting vaccinated: What we know so far

JK News Service by JK News Service
January 19, 2021
in Top Stories
A A
FacebookTwitterWhatsapp

As many as 29 people above the age of 75 died in Norway after getting vaccinated for Covid-19. Pfizer’s BioNTech Covid-19 vaccine is the only vaccine available in Norway.

The number of people above 75 with serious underlying health conditions who died after taking vaccines for the coronavirus (Covid-19) disease in Norway went up to 29 on Saturday. The Scandinavian country, which has inoculated more than 25,000 people since the vaccination drive began on December 27 last year, has confirmed the deaths.

Earlier, the age group thought to be in the danger zone was above 80, but the fresh six deaths on Saturday further lowered it to 75 and also raised questions over which groups to target in national inoculation programme.

Previous Post

DAL LAKE REVERBERATES TO THE ‘SHAURYA’ MUSICAL TALENT HUNT

Next Post

DAL LAKE REVERBERATES TO THE ‘SHAURYA’ MUSICAL TALENT HUNT

Next Post

DAL LAKE REVERBERATES TO THE ‘SHAURYA’ MUSICAL TALENT HUNT

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

  • Home
  • Our Team
  • About Us
  • Contact Us
Dalgate, Near C.D hospital Srinagar Jammu and Kashmir. Pincode: 190001.
Email us: editorjkns@gmail.com

© JKNS - Designed and Developed by GITS.

No Result
View All Result
  • Home
  • Top Stories
  • Kashmir
  • Jammu
  • National
  • Business
  • Sports
  • Oped
  • World

© JKNS - Designed and Developed by GITS.

This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.